Publications by authors named "Josef Birkmann"

Claim this Profile
C
Correction: Dexa-BEAM versus MIFAP as salvage regimen for recurrent lymphoma: a prospective randomized multicenter phase II trial with a median follow‑up of 14.4 years.
Sabine Kürzel, André-René Blaudszun, Lilly Stahl, Regina Herbst, Frank Kroschinsky, Josef Birkmann

J Cancer Res Clin Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune activating and inhibiting effects of calcitriol on γδ T cells and NK cells.
Anna Bold, Heike Gross, Elisabeth Holzmann, Manfred Smetak, Josef Birkmann

Immunobiology· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dexa-BEAM versus MIFAP as salvage regimen for recurrent lymphoma: a prospective randomized multicenter phase II trial with a median follow-up of 14.4 years.
Sabine Kürzel, André-René Blaudszun, Lilly Stahl, Regina Herbst, Frank Kroschinsky, Josef Birkmann

J Cancer Res Clin Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Immunotherapy Against B-Cell Malignancies Using γδ T-Cell-specific Stimulation and Therapeutic Monoclonal Antibodies.
Timm Hoeres, Dominik Pretscher, Elisabeth Holzmann, Manfred Smetak, Josef Birkmann

J Immunother· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing Unmet Information Needs: Results of a Clinician-Led Consultation Service About Complementary and Alternative Medicine for Cancer Patients and Their Relatives.
Markus Horneber, Gerd van Ackeren, Felix Fischer, Herbert Kappauf, Josef Birkmann

Integr Cancer Ther· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 signaling modulates interferon-γ production by Gamma Delta (γδ) T-Cells in response to leukemia.
Timm Hoeres, Elisabeth Holzmann, Manfred Smetak, Josef Birkmann, Martin Wilhelm

Oncoimmunology· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe Drug-Induced Liver Injury as an Adverse Drug Event of Antibiotics: A Case Report and Review of the Literature.
Martin Munz, Hans Grummich, Josef Birkmann, Martin Wilhelm, Ulrike Holzgrabe

Chemotherapy· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azathioprine-induced reversible EBV-associated Hodgkin-like lymphoma after immunosuppressive therapy for autoimmune hepatitis
.
Martin Munz, Dominik Pretscher, Martin Wilhelm, Ulrike Holzgrabe, Fritz Sörgel, Josef Birkmann

Int J Clin Pharmacol Ther· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refractory plasmablastic lymphoma-a review of treatment options beyond standard therapy.
Dominik Pretscher, Alexander Kalisch, Martin Wilhelm, Josef Birkmann

Ann Hematol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mucosal relapse one year after complete remission of cutaneous sporotrichoid leishmaniasis due to Leishmania braziliensis.
Angeliki A Ntasou, Hans Grummich, Klaus Fischer, Vera Baur, Viktor Bonkowsky, Josef Birkmann

Eur J Dermatol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective, Multicenter Study of 5-Fluorouracil Therapeutic Drug Monitoring in Metastatic Colorectal Cancer Treated in Routine Clinical Practice.
Martin Wilhelm, Lothar Mueller, M Craig Miller, Karin Link, Stefan Holdenrieder, Josef Birkmann

Clin Colorectal Cancer· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network.
Olivier Hermine, Eva Hoster, Jan Walewski, André Bosly, Stephan Stilgenbauer, Josef Birkmann

Lancet· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progressive multifocal leukoencephalopathy in patients with a hematological malignancy: review of therapeutic options.
Alexander Kalisch, Martin Wilhelm, Frank Erbguth, Josef Birkmann

Chemotherapy· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful adoptive transfer and in vivo expansion of haploidentical γδ T cells.
Martin Wilhelm, Manfred Smetak, Kerstin Schaefer-Eckart, Brigitte Kimmel, Josef Birkmann

J Transl Med· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of central nervous system (CNS)-directed chemotherapy including high-dose chemotherapy with autologous stem cell transplantation for CNS relapse of aggressive lymphomas.
Agnieszka Korfel, Thomas Elter, Eckhard Thiel, Matthias Hänel, Robert Möhle, Josef Birkmann

Haematologica· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients.
Peter Renner, Stefania Milazzo, Jian Ping Liu, Marcel Zwahlen, Josef Birkmann

Cochrane Database Syst Rev· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-promoting versus tumor-antagonizing roles of γδ T cells in cancer immunotherapy: results from a prospective phase I/II trial.
Volker Kunzmann, Manfred Smetak, Brigitte Kimmel, Karin Weigang-Koehler, Mariele Goebeler, Josef Birkmann

J Immunother· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of concurrent topotecan and radiation on 6-month progression-free survival in the primary treatment of glioblastoma multiforme.
Gerhard G Grabenbauer, Klaus-Dieter Gerber, Oliver Ganslandt, Andrea Richter, Gunther Klautke, Josef Birkmann

Int J Radiat Oncol Biol Phys· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction of HLA-DR+ lymphocytes after treatment with enzastaurin in patients with metastatic thyroid cancer.
Manfred Smetak, Karin Weigang-Koehler, Axel Hanauske, Ute Ohnmacht, Michael Lahn, Josef Birkmann

Chemotherapy· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Equitoxicity of bolus and infusional etoposide: results of a multicenter randomised trial of the German High-Grade Non-Hodgkins Lymphoma Study Group (DSHNHL) in elderly patients with refractory or relapsing aggressive non-Hodgkin lymphoma using the CEMP regimen (cisplatinum, etoposide, mitoxantrone and prednisone).
Carsten Zwick, Josef Birkmann, Norma Peter, Heinrich Bodenstein, Roland Fuchs

Ann Hematol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dexamethasone, high-dose cytarabine, and cisplatin in combination with rituximab as salvage treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma.
Ulrich J M Mey, Katjana S Orlopp, Dimitri Flieger, John W Strehl, Anthony D Ho, Josef Birkmann

Cancer Invest· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A CD33-specific single-chain immunotoxin mediates potent apoptosis of cultured human myeloid leukaemia cells.
Michael Schwemmlein, Matthias Peipp, Karin Barbin, Domenica Saul, Bernhard Stockmeyer, Josef Birkmann

Br J Haematol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to chemotherapy and treating institution predict survival in primary central nervous system lymphoma.
Agnieszka Korfel, Peter Martus, Mohammad R Nowrousian, Dieter K Hossfeld, Heinz Kirchen, Josef Birkmann

Br J Haematol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized study to evaluate the use of high-dose therapy as part of primary treatment for "aggressive" lymphoma.
Ulrich Kaiser, Irmgard Uebelacker, Ulrich Abel, Josef Birkmann, Lorenz Trümper

J Clin Oncol· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis